Demographics (3)
- age - Subject age (phv00348677.v2.p1)
- sex - Gender of participant (phv00348675.v2.p1)
- sex - Gender of participant (phv00520188.v1.p1)
Disease Events (4)
- AFFECTION_STATUS - Case control status of the subject for SCCOHT (phv00520189.v1.p1)
- age_onset - Disease onset age (phv00348674.v2.p1)
- IS_TUMOR - Tumor status (phv00348681.v2.p1)
- TUMOR_STAGE - Tumor stage of sample (phv00348685.v2.p1)
Race and Ethnicity (1)
- race - Race of participant (phv00348676.v2.p1)
Other (15)
- ANALYTE_TYPE - Analyte Type (phv00348680.v2.p1)
- BODY_SITE - Body site where sample was collected (phv00348679.v2.p1)
- CONSENT - Consent group as determined by DAC (phv00348668.v2.p1)
- GEO_ACCESSION - GEO accession ID (phv00354236.v2.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00348682.v2.p1)
- PRIMARY_METASTATIC_TUMOR - Primary tumor, metastasis, or transformed cell line (phv00348683.v2.p1)
- PRIMARY_TUMOR_LOCATION - Primary tumor location (phv00348684.v2.p1)
- SAMPLE_ID - De-identified Sample ID (phv00348678.v2.p1)
- SAMPLE_ID - Sample ID (phv00348671.v2.p1)
- SAMPLE_ID - Sample ID (phv00354235.v2.p1)
- SAMPLE_USE - Sample use (phv00520190.v1.p1)
- SEQUENCING_CENTER - Name of the center which conducted sequencing (phv00348686.v2.p1)
- SUBJECT_ID - De-identified Subject ID (phv00348673.v2.p1)
- SUBJECT_ID - Subject ID (phv00348667.v2.p1)
- SUBJECT_ID - Subject ID (phv00348670.v2.p1)